Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
STE passed our risk checks.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Robust Revenue Growth And Expanding Margins In The Medical Equipment Sector
STERIS plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$236.75 |
52 Week High | US$248.24 |
52 Week Low | US$195.47 |
Beta | 0.84 |
11 Month Change | 0.14% |
3 Month Change | 7.84% |
1 Year Change | 6.55% |
33 Year Change | 15.89% |
5 Year Change | 67.66% |
Change since IPO | 11,378.79% |
Recent News & Updates
Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16Earnings Tell The Story For STERIS plc (NYSE:STE)
Sep 13Steris: Q2 Numbers Solidify Buy Thesis
Aug 13STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price
Aug 08Recent updates
Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16Earnings Tell The Story For STERIS plc (NYSE:STE)
Sep 13Steris: Q2 Numbers Solidify Buy Thesis
Aug 13STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price
Aug 08When Should You Buy STERIS plc (NYSE:STE)?
Jul 04Is STERIS (NYSE:STE) Using Too Much Debt?
Jun 13Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12Shareholder Returns
STE | US Medical Equipment | US Market | |
---|---|---|---|
7D | -1.1% | -1.1% | 0.6% |
1Y | 6.6% | 19.7% | 32.1% |
Return vs Industry: STE underperformed the US Medical Equipment industry which returned 21.1% over the past year.
Return vs Market: STE underperformed the US Market which returned 31.9% over the past year.
Price Volatility
STE volatility | |
---|---|
STE Average Weekly Movement | 2.8% |
Medical Equipment Industry Average Movement | 8.7% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: STE has not had significant price volatility in the past 3 months.
Volatility Over Time: STE's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 18,000 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
STE fundamental statistics | |
---|---|
Market cap | US$23.31b |
Earnings (TTM) | US$560.90m |
Revenue (TTM) | US$5.23b |
41.6x
P/E Ratio4.5x
P/S RatioIs STE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
STE income statement (TTM) | |
---|---|
Revenue | US$5.23b |
Cost of Revenue | US$2.95b |
Gross Profit | US$2.28b |
Other Expenses | US$1.72b |
Earnings | US$560.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.69 |
Gross Margin | 43.60% |
Net Profit Margin | 10.71% |
Debt/Equity Ratio | 36.3% |
How did STE perform over the long term?
See historical performance and comparison